The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Inhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic Disorders
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hannon, G. J. (2002) · Nature · doi:10.1038/418244a · Cited by 3,538
Protein Oxidation in Aging, Disease, and Oxidative Stress
Berlett, B. S., & Stadtman, E. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20313 · Cited by 3,332
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Dietary polyunsaturated fatty acids and inflammatory mediator production
James, M. J., Gibson, R. A., & Cleland, L. G. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.343s · Cited by 1,125
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000
Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2
Bonventre, J. V., Huang, Z., Taheri, M. R., O'Leary, E., Li, E., Moskowitz, M. A., & Sapirstein, A. (1997) · Nature · doi:10.1038/37635 · Cited by 845
Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802
Teyler, T. J., & DiScenna, P. (1987) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.10.030187.001023 · Cited by 788
Neurodegenerative Diseases and Prions
Prusiner, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442006 · Cited by 772
Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N., & Bazan, N. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402531101 · Cited by 753 · cited 3×
“The generation of docosanoids may 604 FAROOQUI ET AL. be an internal protective mechanism for preventing brain damage (Horrocks and Farooqui, 2004; Mukherjee et al., 2004; Serhan et al., 2004).”
Polyunsaturated fatty acids, inflammation and immunity
Calder, P., & Grimble, R. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601478 · Cited by 729
Increased dopamine transmission in schizophrenia: relationship to illness phases
Laruelle, M., Abi-Dargham, A., Gil, R., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 715
Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model
Calon, F., Lim, G. P., Yang, F., Morihara, T., Teter, B., Ubeda, O., Rostaing, P., Triller, A., Salem, N., Ashe, K. H., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.013 · Cited by 707
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
Korth, C., May, B. C. H., Cohen, F. E., & Prusiner, S. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161274798 · Cited by 673
Kainate, a double agent that generates seizures: two decades of progress
Ben-Ari, Y., & Cossart, R. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01659-3 · Cited by 632
Geisler, F. H., Dorsey, F. C., & Coleman, W. P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106273242601 · Cited by 603
Han, X., Holtzman, D. M., & McKeel, D. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00332.x · Cited by 571
Regulatory Functions of Phospholipase A2
Murakami, M., Nakatani, Y., Atsumi, G.-I., Inoue, K., & Kudo, I. (1997) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v17.i3-4.10 · Cited by 543
Review of Current Evidence for Apoptosis After Spinal Cord Injury
BEATTIE, M. S., FAROOQUI, A. A., & BRESNAHAN, J. C. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.915 · Cited by 521
Self-citationSlow- and tight-binding inhibitors of the 85-kDa human phospholipase A2
Street, I. P., Lin, H. K., Laliberte, F., Ghomashchi, F., Wang, Z., Perrier, H., Tremblay, N. M., Huang, Z., Weech, P. K., & Gelb, M. H. (1993) · Biochemistry · doi:10.1021/bi00074a003 · Cited by 418
Eicosapentaenoic Acid Prevents LPS-Induced TNF-α Expression by Preventing NF-κB Activation
Zhao, Y., Joshi-Barve, S., Barve, S., & Chen, L. H. (2004) · Journal of the American College of Nutrition · doi:10.1080/07315724.2004.10719345 · Cited by 405
Phospholipase A2 in the central nervous system
Sun, G. Y., Xu, J., Jensen, M. D., & Simonyi, A. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300016-jlr200 · Cited by 387
Hashimoto, M., Hossain, S., Shimada, T., Sugioka, K., Yamasaki, H., Fujii, Y., Ishibashi, Y., Oka, J., & Shido, O. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00905.x · Cited by 364
Ceramide 1-Phosphate Is a Direct Activator of Cytosolic Phospholipase A2
Pettus, B. J., Bielawska, A., Subramanian, P., Wijesinghe, D. S., Maceyka, M., Leslie, C. C., Evans, J. H., Freiberg, J., Roddy, P., Hannun, Y. A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309262200 · Cited by 361
Horrocks, L. A., & Farooqui, A. A. (2004) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.12.011 · Cited by 356
Self-citationPhospholipase A2 and Its Role in Brain Tissue
Farooqui, A. A., Yang, H., Rosenberger, T. A., & Horrocks, L. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69030889.x · Cited by 338
Self-citationDoh-ura, K., Iwaki, T., & Caughey, B. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4894-4897.2000 · Cited by 324
Friguet, B., Stadtman, E. R., & Szweda, L. I. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31853-7 · Cited by 311
Serhan, C. N., Gotlinger, K., Hong, S., & Arita, M. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.03.005 · Cited by 310
Gamoh, S., Hashimoto, M., Sugioka, K., Shahdat Hossain, M., Hata, N., Misawa, Y., & Masumura, S. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00107-4 · Cited by 300
Phospholipase A2 (PLA2) Enzymes in Membrane Trafficking: Mediators of Membrane Shape and Function
Brown, W. J., Chambers, K., & Doody, A. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00078.x · Cited by 298
Brain Membrane Phospholipid Alterations in Alzheimer's Disease
Pettegrew, J. W., Panchalingam, K., Hamilton, R. L., & McClure, R. J. (2001) · Neurochemical Research · doi:10.1023/a:1011603916962 · Cited by 292
Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients
Yao, J. K., Leonard, S., & Reddy, R. D. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00095-x · Cited by 290
Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders
Farooqui, A. A., & Horrocks, L. A. (1991) · Brain Research Reviews · doi:10.1016/0165-0173(91)90004-r · Cited by 284
Self-citationBlackwell, G. J., & Flower, R. J. (1983) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071830 · Cited by 283
Arachidonic acid as a neurotoxic and neurotrophic substance
Katsuki, H., & Okuda, S. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00016-o · Cited by 280
Apoptotic and necrotic cell death induced by death domain receptors
Denecker, G., Vercammen, D., Declercq, W., & Vandenabeele, P. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000863 · Cited by 279
Phospholipase A2s in Cell Injury and Death
Cummings, B. S., McHowat, J., & Schnellmann, R. G. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39138-4 · Cited by 261
Riendeau, D., Guay, J., Weech, P. K., Laliberté, F., Yergey, J., Li, C., Desmarais, S., Perrier, H., Liu, S., & Nicoll-Griffith, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40726-5 · Cited by 255
McIntosh, Saatman, Raghupathi, Graham, Smith, Lee, & Trojanowski (1998) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1998.00121.x · Cited by 249
Singer, T. P., Castagnoli, N., Ramsay, R. R., & Trevor, A. J. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb03384.x · Cited by 244
Regulatory Mechanism and Physiological Role of Cytosolic Phospholipase A2
Hirabayashi, T., Murayama, T., & Shimizu, T. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1168 · Cited by 240
Balazs, Z., Panzenboeck, U., Hammer, A., Sovic, A., Quehenberger, O., Malle, E., & Sattler, W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02373.x · Cited by 238
Book Review: Plasmalogens: Workhorse Lipids of Membranes in Normal and Injured Neurons and Glia
Farooqui, A. A., & Horrocks, L. A. (2001) · The Neuroscientist · doi:10.1177/107385840100700308 · Cited by 237
Self-citationGuan, Z., Wang, Y., Cairns, N. J., Lantos, P. L., Dallner, G., & Sindelar, P. J. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199907000-00008 · Cited by 236
Atsumi, G.-I., Tajima, M., Hadano, A., Nakatani, Y., Murakami, M., & Kudo, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13870 · Cited by 235
Strokin, M., Sergeeva, M., & Reiser, G. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705326 · Cited by 228
Prion infection impairs the cellular response to oxidative stress
Milhavet, O., McMahon, H. E. M., Rachidi, W., Nishida, N., Katamine, S., Mangé, A., Arlotto, M., Casanova, D., Riondel, J., Favier, A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250289197 · Cited by 222
Cytosolic Phospholipase A2(cPLA2) Immunoreactivity Is Elevated in Alzheimer's Disease Brain
Stephenson, D. T., Lemere, C. A., Selkoe, D. J., & Clemens, J. A. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0005 · Cited by 219
Role of reactive oxygen species in LPS‐induced production of prostaglandin E2in microglia
Wang, T., Qin, L., Liu, B., Liu, Y., Wilson, B., Eling, T. E., Langenbach, R., Taniura, S., & Hong, J. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02242.x · Cited by 218
Larsson, P. K. A., Claesson, H.-E., & Kennedy, B. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.207 · Cited by 216
ANDERSON, D. K., SAUNDERS, R. D., DEMEDIUK, P., DUGAN, L. L., BRAUGHLER, J. M., HALL, E. D., MEANS, E. D., & HORROCKS, L. A. (1985) · Central Nervous System Trauma · doi:10.1089/cns.1985.2.257 · Cited by 213
Self-citationWalters, E. T. (1994) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60307-4 · Cited by 206
Molecular Cloning of Two New Human Paralogs of 85-kDa Cytosolic Phospholipase A2
Pickard, R. T., Strifler, B. A., Kramer, R. M., & Sharp, J. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8823 · Cited by 203
Oxidative stress and mitochondrial dysfunction in neurodegeneration
Schapira, A. H. V. (1996) · Current Opinion in Neurology · doi:10.1097/00019052-199608000-00003 · Cited by 200
Localization and regulation of cytosolic phospholipase A2
Hirabayashi, T., & Shimizu, T. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00115-3 · Cited by 188
Cytosolic Phospholipase A2 Plays a Key Role in the Pathogenesis of Multiple Sclerosis-like Disease
Kalyvas, A., & David, S. (2004) · Neuron · doi:10.1016/s0896-6273(04)00003-0 · Cited by 185
Activation of Ethanolamine Phospholipase A2 in Brain During Ischemia
Edgar, A. D., Strosznajder, J., & Horrocks, L. A. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb11503.x · Cited by 181
Self-citationPhospholipase A2 isoforms: a perspective
Chakraborti, S. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00144-4 · Cited by 180
Ross, B. M. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830170113015 · Cited by 179
Citicoline: neuroprotective mechanisms in cerebral ischemia
Adibhatla, R. M., Hatcher, J. F., & Dempsey, R. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00697.x · Cited by 179
Mosior, M., Six, D. A., & Dennis, E. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2184 · Cited by 178
Atsumi, G.-I., Murakami, M., Kojima, K., Hadano, A., Tajima, M., & Kudo, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000271200 · Cited by 173
Nordvik, I., Myhr, K.-M., Nyland, H., & Bjerve, K. S. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.102003143.x · Cited by 169
Lazarewicz, J. W., Wroblewski, J. T., & Costa, E. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05771.x · Cited by 167
Membrane lipid changes in laminectomized and traumatized cat spinal cord.
Demediuk, P., Saunders, R. D., Anderson, D. K., Means, E. D., & Horrocks, L. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7071 · Cited by 166
Self-citationNeural membrane phospholipids in alzheimer disease
Wells, K., Farooqui, A. A., Liss, L., & Horrocks, L. A. (1995) · Neurochemical Research · doi:10.1007/bf00992508 · Cited by 166
Self-citationMembrane Phospholipid Alterations In Alzheimer's Disease: Deficiency of Ethanolamine Plasmalogens
Farooqui, A. A., Rapoport, S. I., & Horrocks, L. A. (1997) · Neurochemical Research · doi:10.1023/a:1027380331807 · Cited by 163
Self-citationMüller, W. E. G., Ushijima, H., Schröder, H. C., Forrest, J. M. S., Schatton, W. F. H., Rytik, P. G., & Heffner-Lauc, M. (1993) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(93)90040-g · Cited by 159
Kriem, B., Sponne, I., Fifre, A., Malaplate, C., Lozac'h‐Pillot, K., Koziel, V., Yen, F. T., Bihain, B. E., Oster, T., Olivier, J. L., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-1807fje · Cited by 158
Pyrrolidine Inhibitors of Human Cytosolic Phospholipase A2
Seno, K., Okuno, T., Nishi, K., Murakami, Y., Watanabe, F., Matsuura, T., Wada, M., Fujii, Y., Yamada, M., Ogawa, T., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9905155 · Cited by 157
Mazière, C., Conte, M.-A., Degonville, J., Ali, D., & Mazière, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1644 · Cited by 155
Han, W. K., Sapirstein, A., Hung, C. C., Alessandrini, A., & Bonventre, J. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300424200 · Cited by 150
Vitamin E inhibits platelet phospholipase A2
Douglas, C. E., Chan, A. C., & Choy, P. C. (1986) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(86)90053-6 · Cited by 150
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines
May, B. C. H., Fafarman, A. T., Hong, S. B., Rogers, M., Deady, L. W., Prusiner, S. B., & Cohen, F. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2627988100 · Cited by 149
Rordorf, G. A., Uemura, Y., & Bonventre, J. V. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01829.1991 · Cited by 148
Shanker, G., & Aschner, M. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00642-3 · Cited by 146
Increased phospholipase C activity after experimental brain injury
Wei, E. P., Lamb, R. G., & Kontos, H. A. (1982) · Journal of neurosurgery · doi:10.3171/jns.1982.56.5.0695 · Cited by 144
Identification and Purification of Calcium‐Independent Phospholipase A2 from Bovine Brain Cytosol
Hirashima, Y., Farooqui, A. A., MILLS, J. S., & Horrocks, L. A. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09426.x · Cited by 139
Self-citationPhospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2
Hanasaki, K., & Arita, H. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00022-9 · Cited by 139
Kurrasch‐Orbaugh, D. M., Parrish, J. C., Watts, V. J., & Nichols, D. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01921.x · Cited by 138
Clark, M. A., Conway, T. M., Shorr, R., & Crooke, S. T. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61362-6 · Cited by 138
Regulation of arachidonic acid availability for eicosanoid production
Leslie, C. C. (2004) · Biochemistry and Cell Biology · doi:10.1139/o03-080 · Cited by 138
Evidence for Oxidative Stress in Experimental Prion Disease
Guentchev, M., Voigtländer, T., Haberler, C., Groschup, M. H., & Budka, H. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0290 · Cited by 138
Tl, S., Ong, W., Horrocks, L. A., et al. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01552-7 · Cited by 135
Self-citationClemens, J. A., Stephenson, D. T., Smalstig, E. B., Roberts, E. F., Johnstone, E. M., Sharp, J., Little, S. P., & Kramer, R. M. (1996) · Stroke · doi:10.1161/01.str.27.3.527 · Cited by 134
Hossain, S., Hashimoto, M., Gamoh, S., & Masumura, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721133.x · Cited by 134
Deacylation and Reacylation of Neural Membrane Glycerophospholipids: A Matter of Life and Death
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:14:3:123 · Cited by 133
Self-citationMice Deficient in Group IV Cytosolic Phospholipase A2 Are Resistant to MPTP Neurotoxicity
Klivènyi, P., Beal, M. F., Ferrante, R. J., et al. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062634.x · Cited by 129
Phospholipase A 2 , Hydroxyl Radicals, and Lipid Peroxidation in Transient Cerebral Ischemia
Adibhatla, R. M., Hatcher, J. F., & Dempsey, R. J. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603770310329 · Cited by 127
Brain Phospholipase A2 Is Activated After Experimental Closed Head Injury in the Rat
Shohami, E., Shapira, Y., Yadid, G., Reisfeld, N., & Yedgar, S. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb08550.x · Cited by 126
Farooqui, A. A. (2001) · Brain Research Reviews · doi:10.1016/s0169-328x(01)00214-5 · Cited by 126
Self-citationDeletion of cytosolic phospholipase A 2 suppresses Apc Min -induced tumorigenesis
Hong, K. H., Bonventre, J. C., O’Leary, E., Bonventre, J. V., & Lander, E. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051635898 · Cited by 126
Ábrahám, I. M., Harkany, T., Horvath, K. M., & Luiten, P. G. M. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00705.x · Cited by 125
Translocation of phospholipase A2 from cytosol to membranes in rat brain induced by calcium ions
Yoshihara, Y., & Watanabe, Y. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92117-i · Cited by 123
Yang, H., Mosior, M. K., Ni, B., & Dennis, E. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731278.x · Cited by 122
Cultured glial cells express the SNAP-25 analogue SNAP-23
Hepp, R., Perraut, M., Chasserot‐Golaz, S., Galli, T., Aunis, D., Langley, K., & Grant, N. J. (1999) · Glia · doi:10.1002/(sici)1098-1136(199908)27:2<110::aid-glia2>3.0.co;2-c · Cited by 121
85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain
Rintala, J., Seemann, R., Chandrasekaran, K., Rosenberger, T. A., Chang, L., Contreras, M. A., Rapoport, S. I., & Chang, M. (1999) · Neuroreport · doi:10.1097/00001756-199912160-00030 · Cited by 121
Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.
Ross, B., Turenne, S., Moszczynska, A., Warsh, J., & Kish, S. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01123-3 · Cited by 120
Farooqui, A. A., Litsky, M. L., Farooqui, T., & Horrocks, L. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00027-1 · Cited by 119
Self-citationMolecular Characterization of Cytosolic Phospholipase A2-β
Song, C., Chang, X. J., Bean, K. M., Proia, M. S., Knopf, J. L., & Kriz, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17063 · Cited by 119
Rosenberger, T. A., Villacreses, N. E., Hovda, J. T., Bosetti, F., Weerasinghe, G. R., Wine, R. N., Harry, G. J., & Rapoport, S. I. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02246.x · Cited by 119
Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines
Peyrin, J., Lasmézas, C. I., Haı̈k, S., Tagliavini, F., Salmona, M., Williams, A., Richie, D., Deslys, J., & Dormont, D. (1999) · Neuroreport · doi:10.1097/00001756-199903170-00012 · Cited by 115
Fujita, S., Ikegaya, Y., Nishikawa, M., Nishiyama, N., & Matsuki, N. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703970 · Cited by 114
Rao, A. M., & Hatcher, J. F. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10672 · Cited by 113
Effects of Citicoline Combined With Thrombolytic Therapy in a Rat Embolic Stroke Model
Andersen, M., Overgaard, K., Meden, P., Boysen, G., & Choi, S. C. (1999) · Stroke · doi:10.1161/01.str.30.7.1464 · Cited by 110
Modulation of mouse cerebral Na+, K+-ATPase activity by oxygen free radicals
Jamme, I., Petit, E., Divoux, D., Gerbi, A., Maixent, J. M., & Nouvelot, A. (1995) · Neuroreport · doi:10.1097/00001756-199512000-00080 · Cited by 110
Phillis, J. W., & O’Regan, M. H. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.10.002 · Cited by 109
Decreased phospholipase A2 activity in Alzheimer brains
Gattaz, W. F., Maras, A., Cairns, N. J., Levy, R., & Förstl, H. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00123-k · Cited by 108
Genes encoding multiple forms of phospholipase A2 are expressed in rat brain
Molloy, G. Y., Rattray, M., & Williams, R. J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00838-6 · Cited by 105
Trimble, L. A., Street, I. P., Perrier, H., Tremblay, N. M., WEECH, P. K., & Bernstein, M. A. (1993) · Biochemistry · doi:10.1021/bi00210a002 · Cited by 105
Terano, T., Fujishiro, S., Ban, T., Yamamoto, K., Tanaka, T., Noguchi, Y., Tamura, Y., Yazawa, K., & Hirayama, T. (1999) · Lipids · doi:10.1007/bf02562338 · Cited by 105
Rosenberger, T. A., Villacreses, N. E., Hovda, J. T., Bosetti, F., Weerasinghe, G. R., Wine, R. N., Harry, G. J., & Rapoport, S. I. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02613.x · Cited by 105
Excitotoxicity and neurological disorders: involvement of membrane phospholipids.
Farooqui, A., & Horrocks, L. (1994) · International review of neurobiology · doi:10.1016/s0074-7742(08)60306-2 · Cited by 102
Self-citationGronich, J. H., Konieczkowski, M., Gelb, M. H., Nemenoff, R. A., & Sedor, J. R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117076 · Cited by 101
Fuentes, L., Pérez, R., Nieto, M. L., Balsinde, J., & Balboa, M. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307209200 · Cited by 101
Matsuzawa, A., Murakami, M., Atsumi, G.-I., Kazuhiro, I. M. A. I., Prados, P., Inoue, K., & Kudo, I. (1996) · Biochemical Journal · doi:10.1042/bj3180701 · Cited by 99
Gangliosides -- A new therapeutic agent against stroke and Alzheimer's disease
Svennerholm, L. T. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00393-9 · Cited by 98
Kim, D. K., Rordorf, G. A., Nemenoff, R. A., Koroshetz, W. J., & Bonventre, J. V. (1995) · Biochemical Journal · doi:10.1042/bj3100083 · Cited by 97
Kolko, M., DeCoster, M. A., Turco, E., & Bazan, N. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32722 · Cited by 97
Pérez, R., Melero, R., Balboa, M. A., & Balsinde, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402562200 · Cited by 96
Human Group IVC Phospholipase A2(cPLA2γ)
Asai, K., Hirabayashi, T., Houjou, T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212117200 · Cited by 96
Plasmalogens, phospholipases A and signal transduction
Farooqui, A. A., YANG, H., & Horrocks, L. A. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00008-9 · Cited by 96
Self-citationGhelardoni, S., Tomita, Y. A., Bell, J. M., Rapoport, S. I., & Bosetti, F. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.012 · Cited by 95
Localization of cytosolic phospholipase A2 messenger RNA mainly in neurons in the rat brain
Kishimoto, K., Matsumura, K., Kataoka, Y., Morii, H., & Watanabe, Y. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00051-2 · Cited by 92
Long‐term potentiation requires activation of calcium‐independent phospholipase A2
Wolf, M. J., Izumi, Y., Zorumski, C. F., & Gross, R. W. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01371-7 · Cited by 91
Kokotos, G., Six, D. A., Loukas, V., Smith, T., Constantinou‐Kokotou, V., Hadjipavlou‐Litina, D., Kotsovolou, S., Chiou, A., Beltzner, C. C., & Dennis, E. A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030485c · Cited by 91
PLA2 activity is required for nuclear shrinkage in caspase-independent cell death
Shinzawa, K., & Tsujimoto, Y. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200306159 · Cited by 91
Membrane Instability, Plasmalogen Content, and Alzheimer's Disease
Ginsberg, L., Xuereb, J. H., & Gershfeld, N. L. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062533.x · Cited by 90
Zhang, B., Tanaka, J., Yang, L., Yang, L., Sakanaka, M., Hata, R., Maeda, N., & Mitsuda, N. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.057 · Cited by 89
Lin, T., Wang, Q., Simonyi, Á., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02540.x · Cited by 88
Purification of a Novel Calcium-independent Phospholipase A2 from Rabbit Kidney
Portilla, D., & Dai, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15451 · Cited by 87
Chronic Lithium Treatment Decreases Brain Phospholipase A2 Activity
Chang, M., & Jones, C. R. (1998) · Neurochemical Research · doi:10.1023/a:1022415113421 · Cited by 86
Involvement of phospholipase A2 in neurodegeneration
Farooqui, A. A. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00122-2 · Cited by 86
Self-citationArai, K., Ikegaya, Y., Nakatani, Y., Kudo, I., Nishiyama, N., & Matsuki, N. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01623.x · Cited by 86
Lerma, J. (1997) · Neuron · doi:10.1016/s0896-6273(00)80407-9 · Cited by 84
Ong, W., He, Y., Suresh, S., & Patel, S. C. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00608-2 · Cited by 84
Self-citationDe, S., Avilés‐Trigueros, M., Kalyvas, A., & David, S. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00241-0 · Cited by 83
Brain lipid metabolism in the cPLA2 knockout mouse
Rosenberger, T. A., Villacreses, N. E., Contreras, M. A., Bonventre, J. V., & Rapoport, S. I. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200298-jlr200 · Cited by 82
Docosahexaenoic acid reduces GABA response in substantia nigra neuron of rat
Hamano, H., Nabekura, J., Nishikawa, M., & Ogawa, T. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.75.3.1264 · Cited by 82
Phospholipases A2 in Ischemic and Toxic Brain Injury
Sapirstein, A., & Bonventre, J. V. (2000) · Neurochemical Research · doi:10.1023/a:1007583708713 · Cited by 80
Expression and function of phospholipase A2 in brain
Balboa, M. A., Varela‐Nieto, I., Lucas, K. K., & Dennis, E. A. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03481-6 · Cited by 80
Oxidant-mediated AA release from astrocytes involves cPLA2 and iPLA2
Xu, J., Yu, S., Sun, A. Y., & Sun, G. Y. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00152-7 · Cited by 79
Tagami, M., Ikeda, K., Yamagata, K., Nara, Y., Fujino, H., Kubota, A., Numano, F., & Yamori, Y. (1999) · PubMed · Cited by 79
Ateş, M., Hamza, M., Seidel, K., Kotalla, C., Ledent, C. A., & Gühring, H. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02470.x · Cited by 78
Chiba, H., Michibata, H., Wakimoto, K., Seishima, M., Kawasaki, S., Okubo, K., Mitsui, H., Torii, H., & Imai, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305801200 · Cited by 78
Rapoport, S. I. (1999) · Neurochemical Research · doi:10.1023/a:1022584707352 · Cited by 77
Infection specific prion protein (PrP) accumulates on neuronal plasmalemma in scrapie infected mice
Jeffrey, M., Goodsir, C. M., Bruce, M. E., McBride, P., Scott, J. R., & Halliday, W. G. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90785-6 · Cited by 77
Lonergan, P. E., Martin, D. S. D., Horrobin, D. F., & Lynch, M. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02689.x · Cited by 77
n-3 Polyunsaturated fatty acids and human cytokine synthesis
Endres, S., & von Schacky, C. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199602000-00011 · Cited by 77
Ajmone‐Cat, M. A., Nicolini, A., & Minghetti, L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02087.x · Cited by 76
Roles for cytosolic phospholipase A2α as revealed by gene-targeted mice
Uozumi, N., & Shimizu, T. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00021-7 · Cited by 75
Genetic variant near cytosolic phospholipase A2 associated with schizophrenia
Hudson, C. J., Kennedy, J. L., Gotowiec, A. P., Lin, A., King, N. A., Gojtan, K., Macciardi, F. M., Skorecki, K. L., Meltzer, H. Y., Warsh, J. J., et al. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(96)00031-x · Cited by 74
Hazen, S. L., & Gross, R. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98429-2 · Cited by 70
Gangliosides rescue neuronal cells from death after trophic factor deprivation
Ferrari, G. V. D., Batistatou, A. K., & Greene, L. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-05-01879.1993 · Cited by 68
Tabuchi, S., Uozumi, N., ISHII, S., Shimizu, Y., Watanabe, T., & Shimizu, T. (2003) · Springer eBooks · doi:10.1007/978-3-7091-0651-8_36 · Cited by 67
Cloning and Expression of Mouse Liver Phosphatidylserine Synthase-1 cDNA
Stone, S. J., Cui, Z., & Vance, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7293 · Cited by 67
Ibuki, T., Matsumura, K., Yamazaki, Y., Nozaki, T., Tanaka, Y., & Kobayashi, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01848.x · Cited by 66
Retinoic acid-mediated phospholipase A2 signaling in the nucleus
Farooqui, A. A., Antony, P., Ong, W., Horrocks, L. A., & Freysz, L. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.03.002 · Cited by 66
Self-citationSmalheiser, N. R., Dissanayake, S., & Kapil, A. (1996) · Brain Research · doi:10.1016/0006-8993(96)00134-5 · Cited by 66
Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia
Pettegrew, J. W., Klunk, W. E., Kanal, E., Panchalingam, K., & McClure, R. J. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02017-9 · Cited by 66
Tariq, M., Khan, H. A., Moutaery, K. A., & Deeb, S. A. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00427-5 · Cited by 66
New Anti-inflammatory Treatment Strategy in Alzheimer’s Disease
Sugaya, K., Uz, T., Kumar, V., & Manev, H. (2000) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.82.85 · Cited by 65
Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment
DeArmond, S. J., & Prusiner, S. B. (2003) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(02)00041-0 · Cited by 65
Hossain, S., Hashimoto, M., & Masumura, S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00147-5 · Cited by 65
Locati, M., Lamorte, G., Luini, W., Introna, M., Bernasconi, S., Mantovani, A., & Sozzani, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6010 · Cited by 65
Molecular Insights into Alzheimer's Disease
Pettegrew, J. W. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb12486.x · Cited by 64
Fatty acids : physiological and behavioral functions
Mostofsky, D. I., Yehuda, S., & Salem, N. (2001) · Humana Press eBooks · Cited by 63
Bayón, Y., Hernández, M., Alonso, A., Núñez, L., García-Sancho, J., Leslie, C. C., Crespo, M. S., & Nieto, M. L. (1997) · Biochemical Journal · doi:10.1042/bj3230281 · Cited by 63
Platelet phospholipase A 2 activity in Alzheimer?s disease and mild cognitive impairment
Gattaz, W. F., Forlenza, O. V., Talib, L. L., Barbosa, N. R., & Bottino, C. M. C. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0142-y · Cited by 62
Yeo, J.-F., Ong, W., Ling, S.-F., & Farooqui, A. A. (2004) · Pain · doi:10.1016/j.pain.2004.08.009 · Cited by 61
Self-citationCDP-Choline Prevents Glutamate-Mediated Cell Death in Cerebellar Granule Neurons
Mir, C., Clotet, J., Aledo, R., Durany, N., Argemí, J., Lozano, R., Cervós-Navarro, J., & Casals, N. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:1:53 · Cited by 61
Activation of Phospholipase A2 by Amyloid β-Peptides in Vitro
Lehtonen, J. Y. A., Holopainen, J. M., & Kinnunen, P. K. J. (1996) · Biochemistry · doi:10.1021/bi960148o · Cited by 61
Brain Cytosolic Phospholipase A2: Localization, Role, and Involvement in Neurological Diseases
Farooqui, A. A., Ong, W., Horrocks, L. A., et al. (2000) · The Neuroscientist · doi:10.1177/107385840000600308 · Cited by 60
Self-citationPlasmalogens, Docosahexaenoic Acid and Neurological Disorders
Farooqui, A. A., Ong, W., & Horrocks, L. A. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9072-3_45 · Cited by 59
Self-citationMembrane Phospholipids and Cytokine Interaction in Schizophrenia
Yao, J. K., & van Kammen, D. P. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59012-8 · Cited by 58
Bosetti, F., & Weerasinghe, G. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02118.x · Cited by 57
Nutrition and Biochemistry of Phospholipids
Szuchaj, B. F., & van Nieuwenhuyzen, W. (2003) · AOCS Publishing eBooks · doi:10.1201/9781003040330 · Cited by 55
Dempsey, R. J., & Rao, V. L. R. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.98.4.0867 · Cited by 55
Rosales‐Corral, S. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.01.005 · Cited by 53
Flynn, C. J., Farooqui, A. A., & Horrocks, L. A. (1989) · Cited by 53
Self-citationGeddes, J. W., Ułas, J., Brunner, L. C., Choe, W. S., & Cotman, C. W. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90379-g · Cited by 52
Boilard, É., Bourgoin, S. G., Bernatchez, C., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0938com · Cited by 52
Weerasinghe, G. R., Rapoport, S. I., & Bosetti, F. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.04.005 · Cited by 51
DeCoster, M. A., Lambeau, G. J., Lazdunski, M., & Bazan, N. G. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10131 · Cited by 51
4-Alkoxybenzamidines as new potent phospholipase A2 inhibitors
Aitdafoun, M., Mounier, C. M., Heymans, F., Binisti, C., Bon, C., & Godfroid, J. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02172-8 · Cited by 50
Fernando, S. R., & Pertwee, R. G. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701303 · Cited by 50
Tran, K. T., Wong, J. T., Lee, E., Chan, A. C., & Choy, P. C. (1996) · Biochemical Journal · doi:10.1042/bj3190385 · Cited by 49
Does CDP-choline modulate phospholipase activities after transient forebrain ischemia?
Rao, A. M., Hatcher, J. F., & Dempsey, R. J. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03280-7 · Cited by 49
Handbook of Essential Fatty Acid Biology: Biochemistry, Physiology, and Behavioral Neurobiology
(1997) · Humana Press eBooks · doi:10.1007/978-1-4757-2582-7 · Cited by 48
Involvement of the 5‐lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106‐126
Stewart, L. R., White, A. R., Jobling, M. F., Needham, B. E., Maher, F., Thyer, J. M., Beyreuther, K., Masters, C. L., Collins, S. J., & Cappai, R. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1186 · Cited by 47
Estevez, A. Y., & Phillis, J. W. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01450-3 · Cited by 47
Jupp, O. J., Vandenabeele, P., & MacEwan, D. J. (2003) · Biochemical Journal · doi:10.1042/bj20030705 · Cited by 47
Chabot, C., Gagn�, J., Gigu�re, C., Bernard, J., Baudry, M., & Massicotte, G. (1998) · Hippocampus · doi:10.1002/(sici)1098-1063(1998)8:3<299::aid-hipo11>3.0.co;2-w · Cited by 47
Flupirtine Partially Prevents Neuronal Injury Induced by Prion Protein Fragment and Lead Acetate
Perovic, S., Pergande, G., Ushijima, H., Kelve, M., Forrest, J., & Müller, W. E. G. (1995) · Neurodegeneration · doi:10.1006/neur.1995.0044 · Cited by 46
Xing, M., Wilkins, P. L., McConnell, B. K., & Mattera, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42056-4 · Cited by 45
Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide
Latorre, E., Collado, M. P., Fernández, I., Aragonés, M. D., & Catalán, R. E. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03356.x · Cited by 45
Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation
Pinto, F., Brenner, T., Dan, P., Krimsky, M., & Yedgar, S. (2003) · Glia · doi:10.1002/glia.10296 · Cited by 45
Moskowitz, N., Puszkin, S., & Schook, W. J. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00867.x · Cited by 45
Cited by
A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression
Lin, P.-Y., Huang, S.-Y., & Su, K.-P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.018 · Cited by 530
Biochemistry and Physiology of Mammalian Secreted Phospholipases A2
Lambeau, G., & Gelb, M. H. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.062405.154007 · Cited by 513
Adibhatla, R. M., & Hatcher, J. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2668 · Cited by 480
Modulation of inflammation in brain: A matter of fat
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04371.x · Cited by 460
Self-citationLayé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420
Metadata
- Authors
- Farooqui, A. A., Ong, W.-Y., & Horrocks, L. A.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 58
- Issue
- 3
- Pages
- 591-620
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2130109770
- Cited by
- 368
- References
- 250
- FWCI
- 25.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.